| Application no. and date | 18169049.6 (espacenet) (Federated) (European Patent Register), 20050708 | | Patent/reg. no. and date | DK/EP 3406631, 20220629 | | Publication date | 20181128 | | Priority no. and date | US 586581 P, 20040710 | | EP pub. no. and date |
EP 3406631 20181128 | | Effective date | | | Applicant/owner | The Institute for Cancer Research, 333 Cottman Avenue
Philadelphia PA 19111, US | | Applicant ref. no. | V2208-021-DK | | Inventor | Campbell, Kerry S., 2 Hemlock Lane
Wyncote, PA 19095, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 35/12 (2015.01) , A61K 35/17 (2015.01) , A61K 39/395 (2006.01) , A61K 49/00 (2006.01) , C07K 14/705 (2006.01) , C07K 14/735 (2006.01) , C07K 16/28 (2006.01) , C07K 16/32 (2006.01) , C12N 5/00 (2006.01) , C12N 5/0783 (2010.01) , G01N 33/50 (2006.01) | | Title | GENETISK MODIFICEREDE HUMANE NATURLIGE DRÆBERCELLELINJER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
